Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada
Division of Respirology, Dept of Medicine, University of Toronto, Toronto, ON, Canada.
Eur Respir J. 2019 Apr 25;53(4). doi: 10.1183/13993003.02241-2018. Print 2019 Apr.
A high prevalence of suboptimal asthma control is attributable to known evidence-practice gaps. We developed a computerised clinical decision support system (the Electronic Asthma Management System (eAMS)) to address major care gaps and sought to measure its impact on care in adults with asthma.This was a 2-year interrupted time-series study of usual care (year 1) eAMS (year 2) at three Canadian primary care sites. We included asthma patients aged ≥16 years receiving an asthma medication within the last 12 months. The eAMS consisted of a touch tablet patient questionnaire completed in the waiting room, with real-time data processing producing electronic medical record-integrated clinician decision support.Action plan delivery (primary outcome) improved from zero out of 412 (0%) to 79 out of 443 (17.8%) eligible patients (absolute increase 0.18 (95% CI 0.14-0.22)). Time-series analysis indicated a 30.5% increase in physician visits with action plan delivery with the intervention (p<0.0001). Assessment of asthma control level increased from 173 out of 3497 (4.9%) to 849 out of 3062 (27.7%) eligible visits (adjusted OR 8.62 (95% CI 5.14-12.45)). Clinicians escalated controller therapy in 108 out of 3422 (3.2%) baseline visits 126 out of 3240 (3.9%) intervention visits (p=0.12). At baseline, a short-acting β-agonist alone was added in 62 visits and a controller added in 54 visits; with the intervention, this occurred in 33 and 229 visits, respectively (p<0.001).The eAMS improved asthma quality of care in real-world primary care settings. Strategies to further increase clinician uptake and a randomised controlled trial to assess impact on patient outcomes are now required.
高比例的哮喘控制不佳归因于已知的证据实践差距。我们开发了一个计算机临床决策支持系统(电子哮喘管理系统(eAMS))来解决主要的护理差距,并试图衡量其对加拿大三个初级保健站点的成年哮喘患者护理的影响。这是一项为期两年的常规护理(第 1 年)和 eAMS(第 2 年)的中断时间序列研究。我们纳入了过去 12 个月内接受过哮喘药物治疗的年龄≥16 岁的哮喘患者。eAMS 包括在候诊室完成的触摸式平板电脑患者问卷,实时数据处理生成电子病历集成的临床医生决策支持。行动计划的实施(主要结果)从 412 名符合条件的患者中 0 名(0%)增加到 443 名中的 79 名(17.8%)(绝对增加 0.18(95%CI 0.14-0.22))。时间序列分析表明,干预后有计划的医生就诊率增加了 30.5%(p<0.0001)。哮喘控制水平的评估从 3497 名符合条件的就诊者中的 173 名(4.9%)增加到 3062 名中的 849 名(27.7%)(调整后的比值比为 8.62(95%CI 5.14-12.45))。在 3422 名基线就诊者中,有 108 名临床医生增加了控制药物治疗,在 3240 名干预就诊者中有 126 名(p=0.12)。在基线时,单独添加短效β-激动剂的有 62 次就诊,添加控制器的有 54 次就诊;有了干预措施,分别有 33 次和 229 次就诊(p<0.001)。eAMS 提高了现实世界初级保健环境中的哮喘护理质量。现在需要采取策略进一步提高临床医生的接受程度,并进行随机对照试验以评估对患者结局的影响。